Mechanically, we demonstrated that miR-92a-3p targeted CDH1/β-catenin signaling in glioma cells, while Notch-1/Akt signaling was the downstream pathway of miR-92a-3p in GSCs. The gene discussed is CDH1; the disease is central nervous system cancer.